TSXV - Delayed Quote CAD

Thiogenesis Therapeutics, Corp. (TTI.V)

Compare
0.5700
-0.0100
(-1.72%)
At close: January 10 at 2:08:32 PM EST
All numbers in thousands
Breakdown
12/31/2023
12/31/2022
2/28/2022
12/31/2021
Total Assets
7,243.0000
6,290.5720
3,431.3600
230.9770
Total Liabilities Net Minority Interest
1,712.8660
307.1510
3,492.4260
1,293.1980
Total Equity Gross Minority Interest
5,530.1340
5,983.4210
-61.0660
-1,062.2210
Total Capitalization
5,530.1340
5,983.4210
-61.0660
-1,062.2210
Common Stock Equity
5,530.1340
5,983.4210
-61.0660
-1,062.2210
Net Tangible Assets
5,530.1340
5,983.4210
-61.0660
-1,062.2210
Working Capital
5,530.1340
5,983.4210
-61.0660
-1,062.2210
Invested Capital
5,530.1340
5,983.4210
-61.0660
-600.3660
Tangible Book Value
5,530.1340
5,983.4210
-61.0660
-1,062.2210
Total Debt
--
--
--
461.8550
Net Debt
--
--
--
399.3060
Share Issued
44,570.5750
38,862.0750
27,910.1750
27,910.1750
Ordinary Shares Number
44,570.5750
38,862.0750
27,910.1750
27,910.1750
12/31/2021 - 4/13/2022

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers